- Home
- CPBI vs COCH Comparison
CPBI vs COCH Comparison
Compare CPBI & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | CPBI | COCH |
|---|---|---|
| Founded | 2023 | 1995 |
| Country | United States | United States |
| Employees | N/A | 42 |
| Industry | | Blank Checks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.5M | 59.7M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | CPBI | COCH |
|---|---|---|
| Price | $17.31 | $0.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 4.1K | ★ 336.4K |
| Earning Date | 06-12-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.80 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $5.81 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.59 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.10 | $0.36 |
| 52 Week High | $17.89 | $1.91 |
Technical Indicators
Market Signals| Indicator | CPBI | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 51.77 | 43.14 |
| Support Level | $17.37 | $0.64 |
| Resistance Level | $17.88 | $0.88 |
| Average True Range (ATR) | 0.31 | 0.07 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 51.28 | 8.74 |
Price Performance
Historical ComparisonAbout CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists mainly of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market area, as well as commercial real estate loans.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.